Addiction is a serious problem worldwide and the maintenance of methadone treatment to treat addiction to opiates can prove tricky. It is said that cannabis can aid this stabilization method. Some of the factors that contribute to addiction include childhood trauma, personality, depression, environmental cues among others. Cannabinoids have been said to be able to treat chronic pain through their neuroprotective and anti inflammatory properties. Cannabinoids are situated naturally in the cannabis plant (cannabis sativa).
Cannabinoids include tetrahydrocannabinol (THC) and cannabinol (CBD). THC is the psychoactive part of cannabis and gives you the stoned feeling when ingested. CBD is the medicinal constituent of marijuana and this provides you the feeling of being relaxed. The endocannabinoid network bares two cannabinoid receptors, 1 and 2, that allow cannabinoids to bind and work throughout the body.
This paper will divulge into the previous statement in which cannabinoids may or may not have the ability to lend a hand to the burden of opiate addiction and to the subsequent methadone maintenance that helps with the addiction withdrawal.
Illicit substance application, specifically of marijuana, is quite well known among opiate-reliant people, and has the plausibility to affect treatment in a very troublesome way. To evaluate this, systems of marijuana application prior to and in the presence of methadone maintenance treatment (MMT) were evaluated to test plausible marijuana-associated impacts on MMT, specifically during methadone maintenance.
Retrospective chart evaluation was applied to review outpatient accounts of people undergoing MMT, highlighting selectively on the past and present marijuana application and its relation with opiate addiction chastity, methadone dose balance, and treatment conformity.
Goal rates of marijuana application were high during methadone induction, decreasing massively following administration stabilization. The past of marijuana application correlated with marijuana application during MMT, but did not negatively affect the methadone inhibiting method. Early data also indicated that objective levels of opiate endo departure decrease in MMT people applying marijuana during maintenance .
Further in depth reviews will be required to clear up whether marijuana does indeed reduce endo departure symptoms during maintenance and whether it may be related to the treatment prediction method. More so, many people within this sample actually applied marijuana and illegal benzodiazepine addiction during MMT. Regrettably, the condition of the data allowed it not at all impossible to mediate for benzodiazepine application.
Therefore, carefully-mediated research will be needed to see whether concurrent application of marijuana and benzodiazepines on the onset of methadone exhibition concludes in more, subtractive, or synergistic decreases in opiate endo departure signs. More studies are needed to evaluate this statement.